Mortality and rebleeding following variceal haemorrhage in liver cirrhosis and periportal fibrosis

Table 3 Endoscopy findings and endoscopic management in 94 patients with liver cirrhosis and periportal fibrosis presenting with acute variceal haemorrhage n (%)

Variable	PPF (n = 62)	Cirrhosis (n = 32)	P value
Grade II OV	5 (8.1)	2 (6.3)	0.961
Grade III OV	17 (27.4)	10 (31.3)
Grade IV OV	23 (37.1)	14 (43.8)
Gastric varices	17 (27.4)	6 (18.8)
Band ligation	8 (12.9)	1 (3.1)	0.318
Sclerotherapy	45 (72.6)	28 (87.5)
Histoacryl injection	4 (6.5)	2 (6.3)
Both histoacrylandsclerotherapy/band	5 (8.1)	1 (3.1)

OV: Oesophageal varices; PPF: Periportal fibrosis.